Stabilization of Respiratory Function in Pediatric Spinal Muscular Atrophy Treated with Nusinersen [PDF]
Archana Chacko +3 more
openalex +1 more source
Mid- and long-term (at least 12 months) follow-up of patients with spinal muscular atrophy (SMA) treated with nusinersen, onasemnogene abeparvovec, risdiplam or combination therapies: A systematic review of real-world study data [PDF]
Judit Erdös, Claudia Wild
openalex +1 more source
Cerebrospinal fluid characteristics of patients treated with intrathecal nusinersen for spinal muscular atrophy [PDF]
Rotem Orbach +6 more
openalex +1 more source
POSB339 Real-World Adherence of Nusinersen for the Treatment of Spinal Muscular Atrophy (SMA) Using US Large Administrative Claims Dataset [PDF]
Nicole B. Johnson +4 more
openalex +1 more source
CRISPRi-based radiation modifier screen identifies long non-coding RNA therapeutic targets in glioma. [PDF]
BackgroundLong non-coding RNAs (lncRNAs) exhibit highly cell type-specific expression and function, making this class of transcript attractive for targeted cancer therapy.
Akeson, Mark +20 more
core +1 more source
P.166 Subcutaneous intrathecal catheter and port implants for administration of Nusinersen in patients with Spinal Muscular Atrophy [PDF]
A Bokeris, D Mcneely, J Sheriko
openalex +1 more source
An observational cohort study on pulmonary function in adult patients with 5q-spinal muscular atrophy under nusinersen therapy [PDF]
Bogdan Bjelica +4 more
openalex +1 more source
Improvement of muscle strength in specific muscular regions in nusinersen-treated adult patients with 5q-spinal muscular atrophy [PDF]
Olivia Schreiber‐Katz +6 more
openalex +1 more source

